{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:20:14Z","timestamp":1783142414858,"version":"3.54.6"},"reference-count":67,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3960\/jslrt.26019","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T22:11:08Z","timestamp":1782598268000},"page":"156-165","source":"Crossref","is-referenced-by-count":0,"title":["Histiocytic sarcoma with a common clonal origin emerged after 33 years from B-cell precursor acute lymphoblastic leukemia"],"prefix":"10.3960","volume":"66","author":[{"given":"Misayo","family":"Miyake","sequence":"first","affiliation":[{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan,"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Tsuyama","sequence":"additional","affiliation":[{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan,"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan,"},{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Togashi","sequence":"additional","affiliation":[{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan,"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan,"},{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Dobashi","sequence":"additional","affiliation":[{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan,"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan,"},{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Okimoto","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Chiba Children\u2019s Hospital, Chiba, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kimitsu Chuo Hospital,\u00a0Chiba, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan,"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan,"},{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Weiss LM, Pileri SA, Chan J KC, <i>et al.<\/i>: Histiocytic sarcoma. In: Swerdlow SH, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed, Lyon, IARC. 2017; pp. 468-470."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: Clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004; 28: 1133-1144.","DOI":"10.1097\/01.pas.0000131541.95394.23"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Alten J, Klapper W, Leuschner I <i>et al.<\/i> Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2015; 62: 1656-1660.","DOI":"10.1002\/pbc.25523"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Bouabdallah R, Ab\u00e9na P, Chetaille B <i>et al.<\/i> True histiocytic lymphoma following B-acute lymphoblastic leukaemia: Case report with evidence for a common clonal origin in both neoplasms. Br J Haematol. 2001; 113: 1047-1050.","DOI":"10.1046\/j.1365-2141.2001.02841.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Castro EC, Blazquez C, Boyd J <i>et al.<\/i> Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature. Pediatr Dev Pathol. 2010; 13: 225-237.","DOI":"10.2350\/09-03-0622-OA.1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Chalasani S, Hennick MR, Hocking WG, Shaw GR, Lawler B. Unusual presentation of a rare cancer: Histiocytic sarcoma in the brain 16 years after treatment for acute lymphoblastic leukemia. Clin Med Res. 2013; 11: 31-35.","DOI":"10.3121\/cmr.2012.1092"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Dalle JH, Leblond P, Decouvelaere A <i>et al.<\/i> Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow transplantation for T-ALL. Leukemia. 2003; 17: 2056-2057.","DOI":"10.1038\/sj.leu.2403075"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Dictor M, Warenholt J, Gy\u00f6rgy C, M\u00e5nsson I, Larsson G. Clonal evolution to histiocytic sarcoma with the BCR\/ABL rearrangement 14 years after acute lymphoblastic leukemia. Leuk Lymphoma. 2009; 50: 1892-1895.","DOI":"10.3109\/10428190903216846"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Feldman AL, Minniti C, Santi M <i>et al.<\/i> Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol. 2004; 5: 248-250.","DOI":"10.1016\/S1470-2045(04)01428-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kumar R, Khan SP, Joshi DD <i>et al.<\/i> Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A. Pediatr Blood Cancer. 2011; 56: 307-310.","DOI":"10.1002\/pbc.22810"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 McClure R, Khoury J, Feldman A, Ketterling R. Clonal relationship between precursor B-cell acute lymphoblastic leukemia and histiocytic sarcoma: A case report and discussion in the context of similar cases. Leuk Res. 2010; 34: e71-e73.","DOI":"10.1016\/j.leukres.2009.08.020"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Soslow RA, Davis RE, Warnke RA, Cleary ML, Kamel OW. True histiocytic lymphoma following therapy for lymphoblastic neoplasms. Blood. 1996; 87: 5207-5212.","DOI":"10.1182\/blood.V87.12.5207.bloodjournal87125207"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Thakral B, Khoury JD. Histiocytic sarcoma: secondary neoplasm or \u201ctransdifferentiation\u201d in the setting of B-acute lymphoblastic leukemia. Blood. 2016; 128: 2475.","DOI":"10.1182\/blood-2016-08-735795"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Venkataraman V, Massoth LR, Sullivan RJ, Friedmann AM. Secondary histiocytic sarcoma with BRAFV600E mutation after T-cell acute lymphoblastic leukemia in a very young child with dramatic response to dabrafenib and trametinib. Pediatr Blood Cancer. 2020; 67: e28200.","DOI":"10.1002\/pbc.28200"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Bassarova A, Tr\u00f8en G, Foss\u00e5 A <i>et al.<\/i> Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX5 gene with loss of expression cannot explain transdifferentiation. J Hematop. 2009; 2: 135-141.","DOI":"10.1007\/s12308-009-0031-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Feldman AL, Arber DA, Pittaluga S <i>et al.<\/i> Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008; 111: 5433-5439.","DOI":"10.1182\/blood-2007-11-124792"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Kumar J, Al-Kawaaz M, Martin BA <i>et al.<\/i> Histiocytic sarcoma with CCND1 gene rearrangement clonally related and transdifferentiated from mantle cell lymphoma. Am J Clin Pathol. 2022; 158: 449-455.","DOI":"10.1093\/ajcp\/aqac087"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Michonneau D, Kaltenbach S, Derrieux C <i>et al.<\/i> BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia. J Clin Oncol. 2014; 32: e117-e121.","DOI":"10.1200\/JCO.2013.49.0078"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 P\u00e9ricart S, Waysse C, Siegfried A <i>et al.<\/i> Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature. Virchows Arch. 2020; 476: 609-614.","DOI":"10.1007\/s00428-019-02691-w"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Stoecker MM, Wang E. Histiocytic\/dendritic cell transformation of B-cell neoplasms: pathologic evidence of lineage conversion in differentiated hematolymphoid malignancies. Arch Pathol Lab Med. 2013; 137: 865-870.","DOI":"10.5858\/arpa.2012-0104-RS"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Zeng W, Meck J, Cheson BD, Ozdemirli M. Histiocytic sarcoma transdifferentiated from follicular lymphoma presenting as a cutaneous tumor. J Cutan Pathol. 2011; 38: 999-1003.","DOI":"10.1111\/j.1600-0560.2011.01769.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Zhang D. Histiocytic sarcoma arising from lymphomas via transdifferentiation pathway during clonal evolution. Leuk Lymphoma. 2010; 51: 739-740.","DOI":"10.3109\/10428191003774978"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Ganapule AP, Gupta M, Kokil G, Viswabandya A. Histiocytic sarcoma with acute lymphoblastic leukemia a rare association: case report and literature review. Indian J Hematol Blood Transfus. 2014; 30: 305-308.","DOI":"10.1007\/s12288-014-0375-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Mori M, Matsushita A, Takiuchi Y <i>et al.<\/i> Histiocytic sarcoma and underlying chronic myelomonocytic leukemia: a proposal for the developmental classification of histiocytic sarcoma. Int J Hematol. 2010; 92: 168-173.","DOI":"10.1007\/s12185-010-0603-z"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Onciu M. Histiocytic proliferations in childhood. Am J Clin Pathol. 2004; 122: S128-S136.","DOI":"10.1309\/NNTGETJNJY2UB3Y1"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Wongchanchailert M, Laosombat V. True histiocytic lymphoma following acute lymphoblastic leukemia. Med Pediatr Oncol. 2003; 40: 51-53.","DOI":"10.1002\/mpo.10056"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Alvaro T, Bosch R, Salvad\u00f3 MT, Piris MA. True histiocytic lymphoma of the stomach associated with low-grade B-cell mucosa-associated lymphoid tissue (MALT)-type lymphoma. Am J Surg Pathol. 1996; 20: 1406-1411.","DOI":"10.1097\/00000478-199611000-00013"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Brunner P, Rufle A, Dirnhofer S <i>et al.<\/i> Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor. Leukemia. 2014; 28: 1937-1940.","DOI":"10.1038\/leu.2014.167"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Fernandez-Pol S, Bangs CD, Cherry A, Arber DA, Gratzinger D. Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma. Hum Pathol. 2016; 55: 39-43.","DOI":"10.1016\/j.humpath.2016.04.004"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Hure MC, Elco CP, Ward D <i>et al.<\/i> Histiocytic sarcoma arising from clonally related mantle cell lymphoma. J Clin Oncol. 2012; 30: e49-e53.","DOI":"10.1200\/JCO.2011.38.8553"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Mehrotra S, Pan Z. Fine needle aspiration cytology of histiocytic sarcoma with dendritic cell differentiation: A case of transdifferentiation from low-grade follicular lymphoma. Diagn Cytopathol. 2015; 43: 659-663.","DOI":"10.1002\/dc.23285"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Shao H, Xi L, Raffeld M <i>et al.<\/i> Clonally related histiocytic\/dendritic cell sarcoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: A study of seven cases. Mod Pathol. 2011; 24: 1421-1432.","DOI":"10.1038\/modpathol.2011.102"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Wang E, Hutchinson CB, Huang Q <i>et al.<\/i> Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular\/genetic evidence suggestive of a \u2018transdifferentiation\u2019 during the clonal evolution. Leuk Lymphoma. 2010; 51: 802-812.","DOI":"10.3109\/10428191003699845"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Zhang D, McGuirk J, Ganguly S, Persons DL. Histiocytic\/dendritic cell sarcoma arising from follicular lymphoma involving the bone: a case report and review of literature. Int J Hematol. 2009; 89: 529-532.","DOI":"10.1007\/s12185-009-0300-y"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Ansari J, Naqash AR, Munker R <i>et al.<\/i> Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment. Eur J Haematol. 2016; 97: 9-16.","DOI":"10.1111\/ejh.12755"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Cheon M, Yoo J, Kim HS, Lee M. Enhanced computed tomography and 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in the uncommon histiocytic sarcoma of small intestine arising after gastric large B-cell lymphoma. Diagnostics (Basel). 2023; 13: 3189.","DOI":"10.3390\/diagnostics13203189"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Egan C, Lack J, Skarshaug S <i>et al.<\/i> The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy. Mod Pathol. 2021; 34: 336-347.","DOI":"10.1038\/s41379-020-00673-x"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Etancelin P, Boussaid I. Two sides of the same coin: transdifferentiation from Burkitt lymphoma to histiocytic sarcoma. Blood. 2023; 142: 1576.","DOI":"10.1182\/blood.2023021833"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Fenu EM, Margolskee E, Pillai V. Transdifferentiation of B-lymphoblastic leukemia to histiocytic sarcoma after immunotherapy. Am J Hematol. 2023; 98: E216-E218.","DOI":"10.1002\/ajh.26983"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Osman D, Ahmed R. A rare case of trans-differentiation of follicular lymphoma into histiocytic sarcoma. EJHaem. 2025; 6: e1107.","DOI":"10.1002\/jha2.1107"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Sabatini PJB, Tremblay-LeMay R, Ahmadi Moghaddam P, Delabie JMA, Sakhdari A. Marginal zone lymphoma transdifferentiated to histiocytic sarcoma. Br J Haematol. 2021; 194: 1090-1094.","DOI":"10.1111\/bjh.17582"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Chen W, Lau SK, Fong D <i>et al.<\/i> High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic\/dendritic cell sarcomas. Am J Surg Pathol. 2009; 33: 863-873.","DOI":"10.1097\/PAS.0b013e31819287b8"},{"key":"43","unstructured":"43 Grogan TM, Pileri SA, Chan JKC, <i>et al.<\/i>: Histiocytic sarcoma. In: Swerdlow SH, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, IARC. 2008; pp. 356-357."},{"key":"44","unstructured":"44 Takahashi E, Hung YP.: Histiocytic sarcoma. In: WHO Classification of Tumours Editorial Board (eds): WHO Classification of Tumours series. 5th ed, vol. 11, Lyon, IARC. 2024; pp. 255-257."},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Takahashi E, Nakamura S. Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop. 2013; 53: 1-8.","DOI":"10.3960\/jslrt.53.1"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 van Dongen JJ, Langerak AW, Br\u00fcggemann M <i>et al.<\/i> Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations : report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003; 17: 2257-2317.","DOI":"10.1038\/sj.leu.2403202"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Brumpt C, Delabesse E, Beldjord K <i>et al.<\/i> The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotype. Blood. 2000; 96: 2254-2261.","DOI":"10.1182\/blood.V96.6.2254"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Geyer JT, Yigit N, Miyaguchi A <i>et al.<\/i> Histiocytic sarcoma following B-lymphoblastic leukemia\/lymphoma. Am J Clin Pathol. 2019; 152: 486-494.","DOI":"10.1093\/ajcp\/aqz056"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Egan C, Nicolae A, Lack J <i>et al.<\/i> Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups. Haematologica. 2020; 105: 951-960.","DOI":"10.3324\/haematol.2019.230375"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Shinohara Y, Nakayama S, Aoki M, Nishio J. Histiocytic sarcoma: A review and update. Int J Mol Sci. 2025; 26: 8554.","DOI":"10.3390\/ijms26178554"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Broadwater DR, Conant JL, Czuchlewski DR <i>et al.<\/i> Clinicopathologic features and clinical outcome differences in de novo versus secondary histiocytic sarcomas: A multi-institutional experience and review of the literature. Clin Lymphoma Myeloma Leuk. 2018; 18: e427-e435.","DOI":"10.1016\/j.clml.2018.07.286"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Ford AM, Mansur MB, Furness CL <i>et al.<\/i> Protracted dormancy of pre-leukemic stem cells. Leukemia. 2015; 29: 2202-2207.","DOI":"10.1038\/leu.2015.132"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Bessho F, Takayama N, Fronkova E, Zuna J. Reappearance of acute lymphoblastic leukemia 34 years after initial diagnosis: a case report and study of the origin of the reappeared blasts. Int J Hematol. 2013; 97: 525-528.","DOI":"10.1007\/s12185-013-1289-9"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Tartaglia M, Mehler EL, Goldberg R <i>et al.<\/i> Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001; 29: 465-468.","DOI":"10.1038\/ng772"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Tartaglia M, Niemeyer CM, Fragale A <i>et al.<\/i> Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003; 34: 148-150.","DOI":"10.1038\/ng1156"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Kratz CP, Niemeyer CM, Castleberry RP <i>et al.<\/i> The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome\/myeloproliferative disease. Blood. 2005; 106: 2183-2185.","DOI":"10.1182\/blood-2005-02-0531"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Alfayez M, Issa GC, Patel KP <i>et al.<\/i> The clinical impact of PTPN11 mutations in adults with acute myeloid leukemia. Leukemia. 2021; 35: 691-700.","DOI":"10.1038\/s41375-020-0920-z"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Tartaglia M, Martinelli S, Cazzaniga G <i>et al.<\/i> Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. Blood. 2004; 104: 307-313.","DOI":"10.1182\/blood-2003-11-3876"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Bigenwald C, Roos-Weil D, Pag\u00e8s A <i>et al.<\/i> Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France. Blood Adv. 2025; 9: 2530-2541.","DOI":"10.1182\/bloodadvances.2024015208"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Liu Q, Tomaszewicz K, Hutchinson L <i>et al.<\/i> Somatic mutations in histiocytic sarcoma identified by next generation sequencing. Virchows Arch. 2016; 469: 233-241.","DOI":"10.1007\/s00428-016-1965-2"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Voruz S, Cairoli A, Naveiras O <i>et al.<\/i> Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma. Haematologica. 2018; 103: e39-e41.","DOI":"10.3324\/haematol.2017.179150"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Shanmugam V, Griffin GK, Jacobsen ED <i>et al.<\/i> Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma. Mod Pathol. 2019; 32: 830-843.","DOI":"10.1038\/s41379-018-0200-x"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Hou YH, Srour EF, Ramsey H <i>et al.<\/i> Identification of a human B-cell\/myeloid common progenitor by the absence of CXCR4. Blood. 2005; 105: 3488-3492.","DOI":"10.1182\/blood-2004-07-2839"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Kondo M, Scherer DC, Miyamoto T <i>et al.<\/i> Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature. 2000; 407: 383-386.","DOI":"10.1038\/35030112"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Rodr\u00edguez-Ubreva J, Ciudad L, G\u00f3mez-Cabrero D <i>et al.<\/i> Pre-B cell to macrophage transdifferentiation without significant promoter DNA methylation changes. Nucleic Acids Res. 2012; 40: 1954-1968.","DOI":"10.1093\/nar\/gkr1015"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Xie H, Ye M, Feng R, Graf T. Stepwise reprogramming of B cells into macrophages. Cell. 2004; 117: 663-676.","DOI":"10.1016\/S0092-8674(04)00419-2"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Bocker MT, Hellwig I, Breiling A <i>et al.<\/i> Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging. Blood. 2011; 117: e182-e189.","DOI":"10.1182\/blood-2011-01-331926"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/2\/66_26019\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:13:21Z","timestamp":1783142001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/2\/66_26019\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.26019","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"26019"}}